| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider activity in RGNX over the last quarter tilts toward buying: insiders added a net 102,603 shares worth roughly $949K.
Classified under Biotechnology (Health Care sector), RGNX's insider flows are most useful compared with peers in the same group.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 495.9K | - | - | |
| CEO | 338.1K | $4.43M | - | |
| Other | 206.0K | $2.00M | - | |
| Other | 205.5K | $1.99M | - | |
| CFO | 122.8K | $1.14M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 14, 2024 | Mills Kenneth T.81 | President and CEO | Sale+OE10b5-1 | 15,000 | $21.86 | $327,942.00 | -3.5% | -39.8% | -69.2% | |
| Mar 5, 2024 | Pakola Steve80 | Chief Medical Officer | Sale+OE10b5-1 | 12,878 | $28.36 | $365,220.08 | -10.7% | -40.0% | -74.6% | |
| Feb 14, 2024 | Mills Kenneth T.81 | President and CEO | Sale+OE10b5-1 | 15,000 | $16.76 | $251,348.76 | -3.5% | -5.9% | -56.4% | |
| Jan 16, 2024 | Mills Kenneth T.81 | President and CEO | Sale+OE10b5-1 | 45,000 | $15.18 | $682,992.00 | -9.9% | +18.0% | -51.3% | |
| Jan 3, 2024 | Pakola Steve80 | Chief Medical Officer | Sell10b5-1 | 17,237 | $17.39 | $299,789.35 | -13.9% | +17.3% | -54.6% | |
| Dec 19, 2023 | Mills Kenneth T.81 | President and CEO | Sale+OE10b5-1 | 45,000 | $19.69 | $885,825.00 | -11.2% | +13.9% | -60.4% | |
| Jan 3, 2023 | Pakola Steve80 | Chief Medical Officer | Sell | 3,138 | $22.17 | $69,559.42 | -20.5% | -12.9% | -22.2% | |
| Aug 30, 2022 | Vasista Vittal79 | Chief Financial Officer | Sell | 2,400 | $30.24 | $72,572.64 | -1.7% | -24.1% | -38.4% | |
| Aug 5, 2022 | Vasista Vittal79 | Chief Financial Officer | Sell | 17,680 | $35.18 | $622,034.82 | -11.4% | -39.9% | -49.5% | |
| Aug 1, 2022 | Vasista Vittal79 | Chief Financial Officer | Sell | 2,400 | $31.26 | $75,012.00 | -1.5% | -23.7% | -38.3% |